ProFund Advisors »

Peregrine Pharmaceuticals shares owned by ProFund Advisors

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Peregrine Pharmaceuticals

May 2023Jul 2023Sep 2023Nov 2023Jan 2024Mar 2024May 2024Jul 2024300k400k500k600k700k40k50k60k70k80k
Value ($)Share countHistorical CDMO position of ProFund Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $243k 34k 7.14
2024-03-31 $543k 81k 6.70
2023-09-30 $334k 35k 9.44
2023-06-30 $559k 40k 13.97
2023-03-31 $675k 36k 18.76

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Qualcomm (QCOM)
Applied Materials (AMAT)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Texas Instruments Incorporated (TXN)

View all positions for ProFund Advisors

Top funds holding Peregrine Pharmaceuticals

BlackRock
BlackRock
Point72 Asset Management
Vanguard Group
AltraVue Capital
State Street Corporation
Royal Bank of Canada
First Light Asset Management
Palisade Capital Management
Snyder Capital Management
Portolan Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors
Harbor Capital Advisors

View all funds holding Peregrine Pharmaceuticals